Biopharmaceutics of Liposomal Interleukin 2, Oncolipin

By Neville M.E.   Boni L.T.   Pflug L.E.   Popescu M.C.   Robb R.J.  

Cytokine, Vol. 12, Iss. 11, 2000-11 ,pp. : 1691-1701

Academic Press

Access to resources Recommend Favorite

PRODUCTION AND IN SITU LOCALIZATION OF CUTANEOUS TUMOUR NECROSIS FACTOR  (TNF-) AND INTERLEUKIN 6 (IL-6) FOLLOWING SKIN SENSITIZATION

By Flint M.S.   dearman R.J.   Kimber I.   Hotchkiss S.A.M.  

Cytokine, Vol. 10, Iss. 3, 1998-03 ,pp. : 213-219

Academic Press

Access to resources Recommend Favorite

USE OF AN ANTIBODY AGAINST THE SOLUBLE INTERLEUKIN 2 RECEPTOR α SUBUNIT CAN MODULATE THE STABILITY AND BIODISTRIBUTION OF INTERLEUKIN-2

By Kobayashi H.   Tagaya Y.   Han E-S.   Kim I-S.   Le N.   Paik C.H.   Pastan I.   Nelson D.L.   Waldmann T.A.   Carrasquillo J.A.  

Cytokine, Vol. 11, Iss. 12, 1999-12 ,pp. : 1065-1075

Academic Press

Access to resources Recommend Favorite

EFFECT OF β₂-ADRENOCEPTOR ACTIVATION AND ANGIOTENSIN II ON TUMOUR NECROSIS FACTOR AND INTERLEUKIN 6 GENE TRANSCRIPTION IN THE RAT RENAL RESIDENT MACROPHAGE CELLS

By Nakamura A.   Johns E.J.   Imaizumi A.   Yanagawa Y.   Kohsaka T.  

Cytokine, Vol. 11, Iss. 10, 1999-10 ,pp. : 759-765

Academic Press

Access to resources Recommend Favorite

Interleukin (Il-)15 Has Less Activity Than Il-2 to Promote Type 2 Cytokine Predominance in Tumour-Associated Mononuclear Cells from Lung Cancer Patients

By Takeuchi E.   Yanagawa H.   Suzuki Y.   Shinkawa K.   Bando H.   Sone S.  

Cytokine, Vol. 13, Iss. 2, 2001-01 ,pp. : 119-123

Academic Press

Access to resources Recommend Favorite